Abstract
To date, mutations in 15 actin- or microtubule-associated genes have been associated with the cortical malformation lissencephaly and variable brainstem hypoplasia. During a multicenter review, we recognized a rare lissencephaly variant with a complex brainstem malformation in three unrelated children. We searched our large brain-malformation databases and found another five children with this malformation (as well as one with a less severe variant), analyzed available whole-exome or -genome sequencing data, and tested ciliogenesis in two affected individuals. The brain malformation comprised posterior predominant lissencephaly and midline crossing defects consisting of absent anterior commissure and a striking W-shaped brainstem malformation caused by small or absent pontine crossing fibers. We discovered heterozygous de novo missense variants or an in-frame deletion involving highly conserved zinc-binding residues within the GAR domain of MACF1 in the first eight subjects. We studied cilium formation and found a higher proportion of mutant cells with short cilia than of control cells with short cilia. A ninth child had similar lissencephaly but only subtle brainstem dysplasia associated with a heterozygous de novo missense variant in the spectrin repeat domain of MACF1. Thus, we report variants of the microtubule-binding GAR domain of MACF1 as the cause of a distinctive and most likely pathognomonic brain malformation. A gain-of-function or dominant-negative mechanism appears likely given that many heterozygous mutations leading to protein truncation are included in the ExAC Browser. However, three de novo variants in MACF1 have been observed in large schizophrenia cohorts.
Keywords: ACF7, actin, axonal pathfinding, brainstem hypoplasia, cilia, cytoskeleton, lissencephaly, MACF1, microtubules, midline crossing
Main Text
Microtubules (MTs) and filamentous actin form key structural components of the cytoskeleton, a dynamic intracellular structure that is essential for several basic cell functions, including migration, the formation of cellular processes (including axons and dendrites), axonal guidance, and vesicular trafficking. Mammalian genomes contain two spectraplakins—MACF1 (also known as ACF7) and DST (also known as BPAG1)—that function as actin-MT cross-linkers and essential integrators and modulators of cytoskeletal processes.1, 2, 3
MACF1 is a large gene that expresses many isoforms, several of which are brain specific, through alternative splicing. The N terminus of the major isoforms contains two calponin-homology (CH) domains that bind actin, a plakin domain, and a long spectrin-repeat rod domain that confers flexibility. The C terminus of all isoforms functions as a MT binding domain and contains two calcium-binding EF-hand domains, a zinc-binding GAR (growth-arrest specific 2 or Gas2-related) domain, a positively charged Gly-Ser-Arg (GSR) region, and an EB1-binding SxIP domain.1, 2, 3
This work began after we recognized a complex brain malformation consisting of lissencephaly (LIS), a rare brainstem malformation with deficient midline crossing, and multiple developmental deficits including severe intellectual disability and epilepsy in three unrelated children during intergroup reviews. We next searched our large brain-malformation databases (∼3,300 subjects) and identified the same pattern in another five children for a total of eight, including monozygotic twin sisters and one previously reported Japanese girl (Figures 1, 2, S1, and S2).4
Phenotype
According to our revised classification system for LIS,5 the cortical malformation consists of diffuse pachygyria with thick cortex and a mild posterior gradient more severe than the anterior gradient; it varied from “thin” LIS with mildly thick cortex (7–10 mm) in six of eight individuals to classic LIS with very thick cortex (10–15 mm) in two of eight individuals. We found thin anterior commissures and mildly dysplastic hippocampi in all eight individuals and mildly thin corpus callosum in six of eight subjects.
The brainstem malformation consisted of severe dorso-ventral narrowing of the brainstem mostly in the pons and small ventral prominences on mid-sagittal images (Table 1 and Figures 1 and S1). On axial images, the lower midbrain and entire pons and medulla were narrow on the dorso-ventral axis with a prominent ventral midline cleft but were also very wide, resembling a thick “W” (or wide bird wings when turned upside down), on the right-left axis (see Figures 1B, 1F, and 1J). The base of the pons was small (4–5 mm) in three individuals, tiny (2–3 mm) in three individuals, and absent in two of eight individuals. Cranial nerves could be seen exiting from the ventral surface of both medial and lateral aspects of the dysplastic brainstem. Coronal 3D image reconstructions along the ventral brainstem showed absent or very sparse transverse pontine crossing fibers, uncovering the pyramidal tracts (Figures 2 and S2). The cerebellar vermis was moderately small in two individuals, mildly small in five individuals, and normal in one of eight individuals, whereas the cerebellar hemispheres were mildly small in seven individuals and normal in (the same) one individual. Reconstructed diffusion tensor imaging sequences in one boy (LR17-434) showed small superior cerebellar peduncles and absent anterior and posterior transverse pontine crossing fibers (Figure 3). Similar changes were shown in the previously reported Japanese child.4
Table 1.
Subject ID |
LIS with Brainstem Hypoplasia and Dysplasia |
LIS Only |
|||||||
---|---|---|---|---|---|---|---|---|---|
LR14-088 | LR17-434 | LR16-306 | LR17-450 | LR04-067a1 | LR04-067a2 | LR18-077 | LR18-0704 | LR16-412 | |
Protein Variants | |||||||||
GenBank: NM_012090.5a | p.Cys5177Phe | p.Cys5177Phe | p.Asp5228Tyr | p.Asp5228Tyr | p.Cys5230Phe | p.Cys5230Phe | p.Cys5230Gly | deletion | p.Gly4706Arg |
MACF1-204b | p.Cys7135Phe | p.Cys7135Phe | p.Asp7186Tyr | p.Asp7186Tyr | p.Cys7188Phe | p.Cys7188Phe | p.Cys7188Gly | deletion | p.Gly6664Arg |
Cerebral Hemispheres | |||||||||
LIS severity | PGY diffuse | PGY diffuse | PGY diffuse | PGY diffuse | PGY diffuse | PGY diffuse | PGY diffuse | PGY diffuse | PGY diffuse |
LIS gradient | P > A | P > A | P > A | P > A | A = P | A = P | P > A | P > A | P > A |
LIS cortical thickness | thin (4–7 mm) | thin (4–7 mm) | thick (10–15 mm) | thick (10–15 mm) | thin (4–7 mm) | thin (4–7 mm) | thin (4–7 mm) | thin (4–7 mm) | thin (4–7 mm) |
Hippocampal dysplasia | yes | yes | yes | yes | yes | yes | yes | subtle | subtle |
Thin white matter | yes | yes | yes | yes | yes | yes | yes | yes | yes |
Commissures | |||||||||
Anterior commissure | thin | thin | thinc | thin | borderline thin | borderline thin | thin | thin | normal |
Corpus callosum | thin diffuse | thin diffuse | thin diffused | thin diffused | normal | normal | thin mild | normal | thin mild |
Hippocampal commissure | normal | normal | normal | normal | normal | normal | normal | normal | normal |
Optic chiasm | normal | normal | normal | normal | normal | normal | normal | normal | normal |
Brainstem | |||||||||
Thick tectume | no | no | no | yes | no | no | no | no | no |
Severe narrowing of pons | yes | yes | yes | yes | yes | yes | yes | yes | no |
Wide pons and medulla | yes | yes | yes | yes | yes | yes | yes | yes | subtle |
Base of pons | tiny | tiny | absentc | absent | small | small | small | tiny | no |
Pontine hypoplasia | severe | severe (DTI) | severe | severe | moderate to severe | moderate to severe | moderate to severe | severe | no |
Cerebellum | |||||||||
Vermis hypoplasia | moderate | mild | mild | mild | mild | mild | moderate | no | normal |
Hemisphere hypoplasia | moderate | mild | mild | mild | mildf | mildf | mild | no | normal |
Foliar dysplasia | yes | yes | yes | yes | yes | yes | yes | yes | no |
Abbreviations are as follows: A = P, anterior gradient same as posterior gradient; DTI, diffusion tensor imaging; LIS, lissencephaly; P > A, posterior gradient more severe than anterior gradient; PGY, pachygyria.
GenBank: NM_012090.5 and transcript MACF1-203 (Ensembl: ENST00000361689.6).
Transcript MACF1-204 (Ensembl: ENST00000372915.7).
Low-resolution scan.
Severe hypoplasia of splenium.
Fused colliculi.
Right smaller than left.
All eight children had global developmental delay, severe intellectual disability, axial hypotonia (with limb spasticity in three of eight), and seizures (Table 2). The twin girls were non-verbal and had the most severe intellectual disability, as well as short stature and microcephaly (3–5 standard deviations below the mean), although their pregnancy had been complicated only by gestational diabetes and premature birth at 37 weeks of gestation. One girl spoke more than 40 single words, and another used an assistive language device; the remainder used few or no words. Growth was normal except for in the twins. Seizure types included infantile spasms in two individuals (which resolved after steroid treatment in one), myoclonic seizures in two individuals, and mixed partial and generalized seizures in the remaining four children. Involuntary movements were seen in three of eight individuals, and stereotypies were observed in two others. Cranial-nerve deficits consisted of dysphagia in four individuals, asymmetric facial movements in one individual, strabismus in three individuals, and limited ocular adduction in the previously reported child who improved by 5 years.4 Cortical visual impairment was diagnosed in two children, and left optic-nerve hypoplasia was diagnosed in one, whereas hearing was normal in all. One individual had poor temperature regulation plus a neurogenic bladder and bowel attributed to spinal-cord dysfunction without structural abnormality. No consistent dysmorphic facial features were observed, and no other malformations were found, except for a ventricular septal defect that closed spontaneously in one child.
Table 2.
Subject ID |
LIS with Brainstem Hypoplasia and Dysplasia |
LIS Only |
|||||||
---|---|---|---|---|---|---|---|---|---|
LR14-088 | LR17-434 | LR16-306 | LR17-450 | LR04-067a1 | LR04-067a2 | LR18-077 | LR18-0704 | LR16-412 | |
Protein Variants | |||||||||
GenBank: NM_012090.5,a | p.Cys5177Phe | p.Cys5177Phe | p.Asp5228Tyr | p.Asp5228Tyr | p.Cys5230Phe | p.Cys5230Phe | p.Cys5230Gly | deletionb | p.Gly4706Arg |
MACF1-204c | p.Cys7135Phe | p.Cys7135Phe | p.Asp7186Tyr | p.Asp7186Tyr | p.Cys7188Phe | p.Cys7188Phe | p.Cys7188Gly | deletionb | p.Gly6664Arg |
Identity Data | |||||||||
Sex | female | male | female | male | female | female | male | female | female |
Ethnicity | C (Indian) | C (Dutch) | C (USA) | C (Polish) | C (Hispanic) | C (Hispanic) | C (Syrian) | A (Japanese) | C and A (Filipino) |
Geographic origin | Mumbai | Rotterdam | Bay Area, CA | Warsaw | San Jose, CA | San Jose, CA | London | Saitama | Seattle, WA |
Growth Data | |||||||||
OFC at birth (SD) | 36 cm (+1.1) | ND | ND | 31 cm (−1)d | 32.5 cm (−1.5) | ND | ND | 33.5 cm (+0.4) | ND |
Age at last exam | 5 years | 7.5 years | 5.5 years | 7 years | 16 years | 16 years | 7 years | 2.5 years | 5 years |
Weight (SD) | 13.7 kg (−1.7) | 28 kg (+1) | 13.5 kg (+1.7) | 14 kg (−3) | 35.2 kg (−3) | 29.0 kg (−4) | 22 kg (−0.4) | 10.0 kg (−1.6) | 20.4 kg (+0.7) |
Height (SD) | 105 cm (−0.5) | 128 cm (0) | 103 cm (−1) | 116 cm (−1) | 150 cm (−2) | 137 cm (−4) | 50 cm (−2) | 82.5 cm (−1.6) | 107.9 cm (−0.1) |
OFC (SD) | 50.5 cm (0) | 53 cm (+0.7) | 45.5 cm (−1) | 47 cm (+0.5)e | 49.5 cm (−4) | 47.7 cm (−5) | ND | 47.2 cm (−0.4) | 51.3 cm (0) |
Development and Neurological Data | |||||||||
Developmental delay | global | global | global | global | global | global | global | global | mild |
Hypotonia | yes | yes | yes | yes | yes | yes | yes | no | no |
Spasticity | no | no | no | no | yes | yes | yes (legs) | no | no |
Sitting (age) | yes (1 year) | no | no | no | yes (1 year)f | no | yes (1.5 years) | yes (1 year) | yes (7 months) |
Walking (age) | yes (3 years) | no | no | no | yes (5 years) | no | yes (7 years)g | yes (3 years)h | yes (1.5 years) |
Language (age) | >40 wordsi | 10 syllables | nonej | none | 3 wordsk | 3 wordsk | none | none | yes (1.5 years) |
Intellectual disability | severe | severe | severe | severe | severe | severe | severe | severe | severe |
Seizure onset | 5 months | 6 months | 3 months | 3 months | 7 months | 5 months | 6 months | 5 years | 4 years, 3 months |
Seizure types | ISS | ISS, LGS | SE, LGS | MYO | FSIA, LGS | FSIA, FTCS, GTCS | probable GTCS | MYO, GTCS | FSIA, GTCS |
Dyskinesial | hand flapping | mixed | ND | no | mixed | mixed | mixed | hand waving | no |
Vision abnormalities | CVI, left ONH | no | CVI | no | normal | normal | ND | ND | normal |
Eye movements | abnormal NOS | abnormal NOS | normal | no | nystagmus horizontal | ND | slow tracking | abduction limitedm | normal |
Strabismus | left exotropia | exotropia | ND | no | ND | esotropia | ND | ND | no |
Feeding abnormality | none | impaired, GT | impaired, GT | no | ND | ND | none | none | no |
Other | |||||||||
Feature | VSD closed | none | none | none | none | none | dysmorphicn | none | none |
Abbreviations are as follows: A, Asian; C, Caucasian; CVI, cortical visual impairment; FSIA, focal seizure with impaired awareness; FTCS, focal tonic-clonic seizure; GT, gastrostomy tube; GTCS, generalized tonic-clonic seizure; ISS, infantile spasm; LGS, Lennox-Gastaut epilepsy syndrome with atonic, tonic, tonic-clonic, and myoclonic seizures; MYO, myoclonic seizure; ND, no data available; NOS, not otherwise specified; OFC, occipitofrontal circumference; ONH, optic-nerve hypoplasia; SD, standard deviation; VSD, ventriculoseptal defect.
GenBank: NM_012090.5 and transcript MACF1-203 (Ensembl: ENST00000361689.6).
Deletion of exons 58–89 (p.Ala3540_Arg5192; GenBank: NM_012090.5) or exons 62–93 (p.Ala5498_Arg7150; MACF1-204).
Transcript MACF1-204 (Ensembl: ENST00000372915.7).
OFC at 36 weeks of gestation.
OFC at 1 year.
Sits with support only.
Few steps only.
Walks with support at 3 years.
Also with several word combinations.
Uses Picture Exchange Communication System (PECS).
Words later lost.
Mixed abnormal movements with combinations of chorea, athetosis, dystonia, and (in the twins) ballismus.
Ocular abduction limited to half normal excursion at 2.5 years but improved to normal abduction by 5 years.
Hypertelorism, low nasal bridge, epicanthal folds, and low-set ears.
Genetic Analysis
The nine subjects were ascertained from multiple centers and enrolled in research after written informed consent was provided under protocols approved by institutional review boards at Seattle Children’s Hospital, the University of Washington, Boston Children’s Hospital, and Erasmus University Medical Center. Blood or tissue samples were obtained and genomic DNA was extracted according to standard protocols. Whole-exome sequencing was performed in six trios and one proband in seven different laboratories with sequencing parameters that varied modestly across centers and center-specific pipelines (Table S1 and Supplemental Material and Methods). These data were supplemented by whole-genome sequencing in two trios and Sanger sequencing of small critical regions in two probands (the second twin and LR18-077). When no coding changes were found, we looked for small deletions and duplications by manual inspection of read depth in regions where mutations were found in other affected individuals.
We found recurrent, heterozygous de novo missense variants involving three of the four highly conserved zinc-binding residues in the GAR domain of MACF1 in seven of eight children (Tables 1, 2, and S2 and Figure 4A). All variants were predicted to be deleterious: all CADD scores (28–34) were well above our standard cutoff of 15, and all PolyPhen-2 scores (0.995–0.999) were rated as probably damaging (Table S2). None of these variants were found in gnomAD.
No sequence variants of MACF1 were detected in the Japanese girl,4 but manual inspection of read depth and analysis of exome sequence data with the GATK4 GenomeCNVCaller and of genome data with the Manta SV caller detected a 39.6 kb deletion of exons 62–93 (transcript MACF1-204), causing a predicted in-frame deletion from Ala5498 through Arg7150 (Table S2). This region contains the last ten spectrin repeats, both EF-hand domains, and the first two zinc-binding residues: Cys7133 and Cys7135 (Figures 4A and S3). We designed primers flanking the predicted breakpoints to generate a 1.1 kb PCR product and defined breakpoint-flanking sequences that in the normal genome map to intronic sequences 39.6 kb apart: 5′-CCGGGGATTCTGTGTCATCTTAATA-3′–breakpoint–5′-TACAGTAAGCTGAGATCACACTGT-3′.
The GAR domain mediates MT binding and consists of a novel zinc-binding α-β fold composed of a five-stranded anti-parallel β sheet (β1–β5) flanked by N-terminal (α1) and C-terminal (α2) α helices that pack against the β sheet to form an α/β sandwich.3 The α1-β1 loop and the C-terminal loop flanking α2 contain four highly conserved residues (Cys7133, Cys7135, Asp7186, and Cys7188 according to Ensembl sequence MACF1-204) that coordinate the bound zinc ion.3 Our first seven subjects (including both twins) had recurrent missense variants involving three of the four zinc-binding residues. These are shown with both the standard NCBI sequence GenBank: NM_021090.5 and the longer Ensembl sequence MACF1-204 (Table S2). Hereafter, we refer only to the MACF1-204 transcript, which has been used for most functional studies.3
Genotype-Phenotype Analysis
Although the phenotypes were remarkably similar, we found several subtle differences. The two with p.Cys7135Phe had more severe hypoplasia of the anterior commissure, and the two with p.Asp7186Tyr had more severe LIS. The three with p.Cys7188Phe or p.Cys7188Gly and the child with the intragenic deletion had larger (3–4 mm) nodules representing residual pontine crossing fibers on the ventral surface of the pons; these were not seen or barely seen in the other four individuals (Table 1).
Protein Structure
We used the 3D modeling tool PyMOL to predict the effect of missense variants on protein structure of the GAR domain, which was previously resolved by molecular crystallography (Supplemental Material and Methods).3 This region contains a sandwich structure and a divalent zinc-binding pocket formed by four highly conserved amino acids (three cysteines and one aspartate) that are invariant in spectraplakins and essential for MT binding. Substitutions involving these residues were predicted to significantly alter configuration of the zinc-binding pocket (Figure 4B), which supports experimental data showing compromised domain function when one of the cysteine residues is replaced by a serine and strongly supports pathogenicity of the protein variants, which most likely abrogate MT binding.3
Ciliogenesis
Studies using several cre drivers in mouse Macf1 knockouts demonstrated that loss of Macf1 in the retina, ependymal and cochlear sensory epilthelia, and mouse embryonic fibroblasts led to failure of cells to build cilia and disrupted apicobasal polarity in the retina, whereas heterozygous mutants had normal cilia.6 We hypothesized that heterozygous variants in the GAR domain, if pathogenic, would also disrupt cilia formation, a key cellular function that can be tested in cells exiting mitosis after serum starvation.7 We therefore tested cilium formation in skin fibroblasts from two subjects with MACF1 variants and compared it with that of mutant fibroblasts with known defects in cilium number and length (CEP290) or length alone (RTTN).8
Fibroblast lines from two control and five affected individuals with known mutations (two in MACF1, two in RTTN, and one in CEP290) were processed in parallel in duplicate or quadruplicate as previously described (Supplemental Material and Methods). In brief, cells were grown until they were 80% confluent, serum starved for 48 hr for the induction of cilium formation, fixed with methanol, incubated overnight with primary antibodies—mouse monoclonal anti-human acetylated tubulin (Sigma Aldrich T7451) and rabbit polyclonal anti-human gamma tubulin (Sigma Aldrich T3320)—and then incubated with secondary fluorescent antibodies for 1 hr. Cells with basal bodies (γ-tubulin positive) were scored for cilium length, defined as normal (>3 μm) or short (<3 μm), in four quadrants for each coverslip by one individual. Values indicate the average length ± SEM. Under these conditions, 50%–80% of cells grew cilia according to data from 100 experiments using multiple control fibroblast lines.
In contrast to the mouse homozygous mutants, human fibroblasts carrying MACF1 mutations made normal numbers of cilia, but a significantly larger percentage of cells had short cilia, indicating a length-control deficit similar to that of RTTN-mutant cells (Figure S4). Statistical tests for cilium formation and a length assay were performed with Prism 5 GraphPad.
Phenotype Variant
We also evaluated a ninth child with an overlapping disorder. Brain imaging studies in this girl showed mild, posterior predominant LIS similar to that of the children with variants in the GAR domain but only subtle brainstem dysplasia (Figures S1I–S1L and S2I–S2L). Within the C-terminal portion of the spectrin repeat domain of MACF1, we found a heterozygous de novo missense variant that lies within the genomic region deleted in the Japanese girl (Table S2). This region, designated SR4, contains residues 6,221–6,894 in Ensembl sequence MACF1-204 and mediates binding to GSK3B as well as Axin and APC.9 GSK3B regulates MACF1 binding to MTs and migration of pyramidal neurons to the cortical plate, suggesting a possible mechanism for the defect in neuronal migration.1, 9, 10
Our data demonstrate four missense mutations and one in-frame deletion in MACF1, which encodes zinc-binding residues in the MT-binding GAR domain, in eight children with a rare and distinctive brain malformation consisting of variable but usually mild LIS with a posterior gradient more severe than the anterior gradient, poorly formed hippocampi, an unusual brainstem malformation with very broad, flat pons and upper medulla, and midline-crossing defects involving the anterior commissure, transverse pontine crossing fibers, and probably pyramidal tracts.4 The corpus callosum and cerebellum are less affected. Now being defined, the brain malformation is visually striking and most likely pathognomonic for MACF1 mutations involving the GAR domain. We also identified a de novo variant in the MACF1 spectrin repeat domain in one girl with a similar type of LIS but only a subtle brainstem malformation.
Overlapping Phenotypes
Prior ROBO3- and DCC-associated brainstem malformations associated with deficits in midline crossing have been described as “butterfly-like,” referring to axial images through the low brainstem (OMIM: 617542 and 607313).11, 12, 13, 14 The W-shaped brainstem phenotype associated with MACF1 mutations affecting the zinc-binding pocket is more severe than the “butterfly” configuration. The midline is very narrow and shows a cleft in MRI from individuals with mutations of all three genes. In addition, the medulla and pons are very narrow and wide in subjects with MACF1 mutations, which is not the case in subjects with ROBO3 or DCC mutations. In some of our subjects, the low brainstem resembles bird wings when inverted (Figure S5), but we did not find this (or really the butterfly-like shape with ROBO3 or DCC mutations) consistent enough to support its use. Mutations in DCC are also associated with severe hypoplasia of the anterior commissure and variable agenesis of the corpus callosum. Bi-allelic mutations in ARHGEF2 have been associated with severe hypoplasia of the transverse pontine crossing fibers and an enlarged medulla, but development of the cerebral commissures and other crossing tracts has not been discussed.15
MACF1 in Development
In mice, MACF1 is found in all tissues but most highly in the brain (especially ependymal and mantle layers) and spinal cord.10 Intermediate amounts are present in the dorsal root ganglia, olfactory epithelium, bronchial epithelium, lung, skeletal muscle, myocardium, and adrenal glands. At embryonic day 12.5 (E12.5), MACF1 is localized widely in the brain and most highly in the ventricular zone, where it co-localizes with Nestin-positive ventricular radial glia cells, and in the upper cortical plate and marginal zone, where it co-localizes with MAP2. By E15.5, MACF1 localization expands to the entire cortical plate and subplate but is reduced in the ventricular and subventricular zones. This pattern fits well with its role in regulating neuronal migration.
Mouse Knockouts
Several homozygous Macf1 loss-of-function (LoF) mouse mutants have been described.16, 17 Complete LoF (Macf1−/−) mutant embryos implant and form a neural plate but never develop a primitive streak, node, or axial mesoderm and die at E10.5–E11.5 soon after gastrulation.9 These features resemble the Wnt3 LoF mutant,18 which led to studies showing that loss of MACF1 inhibits Wnt signaling via interactions with Axin, GSK3B, APC, LRP5, LRP6, and β-catenin. The binding sites for these interacting proteins are localized to the plakin and spectrin repeat domains of MACF1.9
Experiments using embryonic neural drivers (NeuroD6-cre or Nestin-cre) or electroporation of small hairpin antisense RNA to knock down Macf1 demonstrated many developmental defects that resemble the human malformation.10, 16 Mouse mutants had disrupted neuronal migration via disruption of microtubule dynamics and GSK3 signaling, as well as pyramidal neurons throughout the mantle, including the subventricular and ventricular zones, and interneurons found mostly in the intermediate zone.10, 16, 19 Some subtypes of radially migrating neurons, including BRN1-, CTIP-, and TBR1-positive neurons, were distributed evenly throughout the mutant cortical plate; conversely, in control brains, they were predominately localized to higher cortical layers. Macf1-deleted neurons had short, unstable leading processes, centrosomes that failed to move into the leading process, and unstable microtubules, resulting in unidirectional and slow radial migration. Similar defects were seen in the developing hippocampus.
Mouse knockouts also had abnormal axonal extension and guidance, including multiple defects in midline crossing. The anterior and hippocampal commissures were severely hypoplastic, and the corpus callosum had reduced numbers of fibers.16 Thalamocortical fiber tracts were thinner and less compact than in control animals and had many fibers misdirected tangentially toward the cortical surface. In addition, a recent transposon-mediated mutagenesis screen using in utero electroporation of mouse embryos to detect mutant neural progenitor (radial glia) cells unable to migrate to the cortex identified 33 candidate genes for malformations of cortical development, one of which was Macf1.20
Defects in axonal extension and guidance have also been seen with mutations in Short stop (shot), the Drosphila MACF1 homolog that interacts with Robo and Slit and regulates midline axon crossing.21 In shot mutants, axonal growth cones initiate at the normal time and have normal morphology, including normal axon orientation and fasciculation. However, sensory and (to a lesser extent) motor axons extend only a short distance beyond the cell body.22
Heterozygous MACF1 LoF Could Be Non-pathogenic
The ExAC Browser includes 14 high- and another 26 low-confidence LoF MACF1 variants, including 19 stop-gained, 16 frameshift, and 5 splice-donor variants. These data imply that heterozygous LoF variants are not pathogenic, even though genome-wide analysis suggested that MACF1 is highly intolerant to LoF mutations (it ranks seventh most intolerant of 18,225 genes studied; pLI = 1.0).23
Alternatively, LoF variants could contribute to neurodevelopmental disorders with incomplete penetrance, given that sequencing studies in three schizophrenia cohorts reported heterozygous de novo MACF1 variants, including one frameshift variant that truncates the protein in the plakin domain and two missense variants in the N-terminal spectrin repeat domain, in three individuals (Table S2 and Figure 4A).24, 25, 26 Both missense variants are located in a MACF1 region that interacts with GSK3B and other proteins known to regulate neuronal migration.9, 10 Notably, several genome-wide association studies have implicated other genes that regulate neuronal migration in the pathogenesis of schizophrenia, such as DISC1, NRG1, and RELN.27, 28, 29, 30 In addition, several reports have described localized malformations of neuronal migration involving entorhinal cortex and subcortical white matter in brains of individuals with schizophrenia.31, 32
Given that the missense variants we report here cause a more severe phenotype (LIS plus midline-crossing defects) than truncations (non-pathogenic or possibly increased risk of schizophrenia), we hypothesize that the variants in the GAR domain act via either altered function (selective loss or gain of function) or a dominant-negative mechanism.
Although not clearly germane to our findings, two prior studies have suggested a link between MACF1 or its chromosomal region and other human disorders. In the first, a boy with diffuse hypotonia from infancy was found to have a partial duplication of chromosomal region 1p34.3 involving more than half of the 3′ end of MACF1. His mother and two full sisters also carried the duplication; all duplication carriers had hypotonia, which varied significantly in severity.33 In the second study, a candidate-gene study of 105 SNPs across MACF1 in 713 families affected by Parkinson disease showed a significant association with a single SNP in the region (dbSNP: rs12118033).34
Summary
We have identified recurrent de novo, heterozygous, missense mutations that involve the zinc ion-binding pocket in the GAR domain of MACF1 and cause defects (resembling those in mouse knockouts) in neuronal migration and axonal pathfinding. In addition, we found that one variant in the spectrin rod domain leads to a neuronal migration defect only. Defining the spectrum of mutations and associated phenotypes will require the discovery of additional mutations in this large and functionally important gene.
Declaration of Interests
The authors declare no competing interests.
Acknowledgments
We thank the families and their referring physicians for their important contributions to our ongoing work on these disorders. This study was funded by the US National Institutes of Health under National Institute of Neurological Disorders and Stroke grants 5R01NS050375 and 1R01NS058721 to W.B.D. and K08NS092898 to G.M.M., National Eye Institute (NEI) grant R01EY027421, and National Heart, Lung, and Blood Institute (NHLBI) grant X01HL132377 to E.C.E. and by Netherlands ErasmusMC Mrace grant 104673 to G.M.S.M. Sequencing and/or data analysis was provided by the University of Washington Center for Mendelian Genomics with support from National Human Genome Research Institute (NHGRI) grant U54HG006493 to D.A.N. and M.J.B., the Center for Mendelian Genomics at the Broad Institute of MIT and Harvard with support from NHGRI, NEI, and NHLBI grant UM1HG008900 to Daniel MacArthur and Heidi Rehm, and the University of Washington IDDRC Genetics Core with support from NHGRI grant U54HG006493 to D.D. Additional funding came from private donations to W.B.D. and D.D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding sources. Please note that the authors cite OMIM according to journal editorial policy but do not endorse the referenced OMIM data.
Published: November 21, 2018
Footnotes
Supplemental Data include Supplemental Material and Methods, five figures, and two tables and can be found with this article online at https://doi.org/10.1016/j.ajhg.2018.10.019.
Contributor Information
William B. Dobyns, Email: wbd@uw.edu.
Grazia M.S. Mancini, Email: g.mancini@erasmusmc.nl.
Accession Numbers
The accession numbers for the disease-associated variants described in this paper are ClinVar: SCV000840387–SCV000840392.
Web Resources
CADD version 1.3, http://cadd.gs.washington.edu/home
ExAC Browser, http://exac.broadinstitute.org
gnomAD, http://gnomad.broadinstitute.org
OMIM, http://omim.org/
UniProt, http://www.uniprot.org/
Supplemental Data
References
- 1.Goryunov D., Liem R.K. Microtubule-actin cross-linking factor 1: domains, interaction partners, and tissue-specific functions. Methods Enzymol. 2016;569:331–353. doi: 10.1016/bs.mie.2015.05.022. [DOI] [PubMed] [Google Scholar]
- 2.Moffat J.J., Ka M., Jung E.M., Smith A.L., Kim W.Y. The role of MACF1 in nervous system development and maintenance. Semin. Cell Dev. Biol. 2017;69:9–17. doi: 10.1016/j.semcdb.2017.05.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lane T.R., Fuchs E., Slep K.C. Structure of the ACF7 EF-hand-GAR module and delineation of microtubule binding determinants. Structure. 2017;25:1130–1138.e6. doi: 10.1016/j.str.2017.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Irahara K., Saito Y., Sugai K., Nakagawa E., Saito T., Komaki H., Nakata Y., Sato N., Baba K., Yamamoto T. Pontine malformation, undecussated pyramidal tracts, and regional polymicrogyria: a new syndrome. Pediatr. Neurol. 2014;50:384–388. doi: 10.1016/j.pediatrneurol.2013.12.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Di Donato N., Chiari S., Mirzaa G.M., Aldinger K., Parrini E., Olds C., Barkovich A.J., Guerrini R., Dobyns W.B. Lissencephaly: expanded imaging and clinical classification. Am. J. Med. Genet. A. 2017;173:1473–1488. doi: 10.1002/ajmg.a.38245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.May-Simera H.L., Gumerson J.D., Gao C., Campos M., Cologna S.M., Beyer T., Boldt K., Kaya K.D., Patel N., Kretschmer F. Loss of MACF1 abolishes ciliogenesis and disrupts apicobasal polarity establishment in the retina. Cell Rep. 2016;17:1399–1413. doi: 10.1016/j.celrep.2016.09.089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Reiter J.F., Leroux M.R. Genes and molecular pathways underpinning ciliopathies. Nat. Rev. Mol. Cell Biol. 2017;18:533–547. doi: 10.1038/nrm.2017.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kheradmand Kia S., Verbeek E., Engelen E., Schot R., Poot R.A., de Coo I.F., Lequin M.H., Poulton C.J., Pourfarzad F., Grosveld F.G. RTTN mutations link primary cilia function to organization of the human cerebral cortex. Am. J. Hum. Genet. 2012;91:533–540. doi: 10.1016/j.ajhg.2012.07.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Chen H.J., Lin C.M., Lin C.S., Perez-Olle R., Leung C.L., Liem R.K. The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. Genes Dev. 2006;20:1933–1945. doi: 10.1101/gad.1411206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ka M., Jung E.M., Mueller U., Kim W.Y. MACF1 regulates the migration of pyramidal neurons via microtubule dynamics and GSK-3 signaling. Dev. Biol. 2014;395:4–18. doi: 10.1016/j.ydbio.2014.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Jen J.C., Chan W.M., Bosley T.M., Wan J., Carr J.R., Rüb U., Shattuck D., Salamon G., Kudo L.C., Ou J. Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis. Science. 2004;304:1509–1513. doi: 10.1126/science.1096437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Hackenberg A., Boltshauser E., Gerth-Kahlert C., Stahr N., Azzarello-Burri S., Plecko B. Horizontal gaze palsy in two brothers with compound heterozygous ROBO3 gene mutations. Neuropediatrics. 2017;48:57–58. doi: 10.1055/s-0036-1597610. [DOI] [PubMed] [Google Scholar]
- 13.Jamuar S.S., Schmitz-Abe K., D’Gama A.M., Drottar M., Chan W.M., Peeva M., Servattalab S., Lam A.N., Delgado M.R., Clegg N.J. Biallelic mutations in human DCC cause developmental split-brain syndrome. Nat. Genet. 2017;49:606–612. doi: 10.1038/ng.3804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Sicotte N.L., Salamon G., Shattuck D.W., Hageman N., Rüb U., Salamon N., Drain A.E., Demer J.L., Engle E.C., Alger J.R. Diffusion tensor MRI shows abnormal brainstem crossing fibers associated with ROBO3 mutations. Neurology. 2006;67:519–521. doi: 10.1212/01.wnl.0000227960.38262.0c. [DOI] [PubMed] [Google Scholar]
- 15.Ravindran E., Hu H., Yuzwa S.A., Hernandez-Miranda L.R., Kraemer N., Ninnemann O., Musante L., Boltshauser E., Schindler D., Hübner A. Homozygous ARHGEF2 mutation causes intellectual disability and midbrain-hindbrain malformation. PLoS Genet. 2017;13:e1006746. doi: 10.1371/journal.pgen.1006746. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Goryunov D., He C.Z., Lin C.S., Leung C.L., Liem R.K. Nervous-tissue-specific elimination of microtubule-actin crosslinking factor 1a results in multiple developmental defects in the mouse brain. Mol. Cell. Neurosci. 2010;44:1–14. doi: 10.1016/j.mcn.2010.01.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wu X., Kodama A., Fuchs E. ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity. Cell. 2008;135:137–148. doi: 10.1016/j.cell.2008.07.045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Liu P., Wakamiya M., Shea M.J., Albrecht U., Behringer R.R., Bradley A. Requirement for Wnt3 in vertebrate axis formation. Nat. Genet. 1999;22:361–365. doi: 10.1038/11932. [DOI] [PubMed] [Google Scholar]
- 19.Ka M., Moffat J.J., Kim W.Y. MACF1 controls migration and positioning of cortical GABAergic interneurons in mice. Cereb. Cortex. 2017;27:5525–5538. doi: 10.1093/cercor/bhw319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Lu I.L., Chen C., Tung C.Y., Chen H.H., Pan J.P., Chang C.H., Cheng J.S., Chen Y.A., Wang C.H., Huang C.W. Identification of genes associated with cortical malformation using a transposon-mediated somatic mutagenesis screen in mice. Nat. Commun. 2018;9:2498. doi: 10.1038/s41467-018-04880-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lee S., Nahm M., Lee M., Kwon M., Kim E., Zadeh A.D., Cao H., Kim H.J., Lee Z.H., Oh S.B. The F-actin-microtubule crosslinker Shot is a platform for Krasavietz-mediated translational regulation of midline axon repulsion. Development. 2007;134:1767–1777. doi: 10.1242/dev.02842. [DOI] [PubMed] [Google Scholar]
- 22.Lee S., Kolodziej P.A. Short Stop provides an essential link between F-actin and microtubules during axon extension. Development. 2002;129:1195–1204. doi: 10.1242/dev.129.5.1195. [DOI] [PubMed] [Google Scholar]
- 23.Lek M., Karczewski K.J., Minikel E.V., Samocha K.E., Banks E., Fennell T., O’Donnell-Luria A.H., Ware J.S., Hill A.J., Cummings B.B., Exome Aggregation Consortium Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–291. doi: 10.1038/nature19057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kenny E.M., Cormican P., Furlong S., Heron E., Kenny G., Fahey C., Kelleher E., Ennis S., Tropea D., Anney R. Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders. Mol. Psychiatry. 2014;19:872–879. doi: 10.1038/mp.2013.127. [DOI] [PubMed] [Google Scholar]
- 25.Wang Q., Li M., Yang Z., Hu X., Wu H.M., Ni P., Ren H., Deng W., Li M., Ma X. Increased co-expression of genes harboring the damaging de novo mutations in Chinese schizophrenic patients during prenatal development. Sci. Rep. 2015;5:18209. doi: 10.1038/srep18209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Xu B., Ionita-Laza I., Roos J.L., Boone B., Woodrick S., Sun Y., Levy S., Gogos J.A., Karayiorgou M. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat. Genet. 2012;44:1365–1369. doi: 10.1038/ng.2446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Ekelund J., Lichtermann D., Hovatta I., Ellonen P., Suvisaari J., Terwilliger J.D., Juvonen H., Varilo T., Arajärvi R., Kokko-Sahin M.L. Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum. Mol. Genet. 2000;9:1049–1057. doi: 10.1093/hmg/9.7.1049. [DOI] [PubMed] [Google Scholar]
- 28.Shifman S., Johannesson M., Bronstein M., Chen S.X., Collier D.A., Craddock N.J., Kendler K.S., Li T., O’Donovan M., O’Neill F.A. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet. 2008;4:e28. doi: 10.1371/journal.pgen.0040028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Hodgkinson C.A., Goldman D., Jaeger J., Persaud S., Kane J.M., Lipsky R.H., Malhotra A.K. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am. J. Hum. Genet. 2004;75:862–872. doi: 10.1086/425586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Li D., Collier D.A., He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum. Mol. Genet. 2006;15:1995–2002. doi: 10.1093/hmg/ddl122. [DOI] [PubMed] [Google Scholar]
- 31.Muraki K., Tanigaki K. Neuronal migration abnormalities and its possible implications for schizophrenia. Front. Neurosci. 2015;9:74. doi: 10.3389/fnins.2015.00074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Yang Y., Fung S.J., Rothwell A., Tianmei S., Weickert C.S. Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia. Biol. Psychiatry. 2011;69:63–70. doi: 10.1016/j.biopsych.2010.08.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Jørgensen L.H., Mosbech M.B., Færgeman N.J., Graakjaer J., Jacobsen S.V., Schrøder H.D. Duplication in the microtubule-actin cross-linking factor 1 gene causes a novel neuromuscular condition. Sci. Rep. 2014;4:5180. doi: 10.1038/srep05180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Wang X., Li N., Xiong N., You Q., Li J., Yu J., Qing H., Wang T., Cordell H.J., Isacson O. Genetic variants of microtubule actin cross-linking factor 1 (MACF1) confer risk for Parkinson’s disease. Mol. Neurobiol. 2017;54:2878–2888. doi: 10.1007/s12035-016-9861-y. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.